| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8816579 | American Journal of Preventive Medicine | 2018 | 9 Pages |
Abstract
The findings indicate that gender identity disparities in cancer screenings persist beyond known sociodemographic and healthcare factors. It is critical that gender identity questions are included in cancer and other health-related surveillance systems to create knowledge to better inform healthcare practitioners and policymakers of appropriate screenings for trans and gender-nonconforming individuals.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Ariella R. MS, Megan E. PhD, Catherine S.J. BS, Kellan E. MA, MPH,